StockNews.com started coverage on shares of Veradigm (NASDAQ:MDRX – Free Report) in a research report report published on Friday morning. The firm issued a hold rating on the software maker’s stock.
Veradigm Price Performance
Shares of Veradigm stock opened at $9.45 on Friday. The company’s fifty day simple moving average is $10.01 and its two-hundred day simple moving average is $9.73. Veradigm has a 12-month low of $5.01 and a 12-month high of $11.80.
Institutional Trading of Veradigm
A hedge fund recently bought a new stake in Veradigm stock. Innealta Capital LLC purchased a new position in Veradigm Inc. (NASDAQ:MDRX – Free Report) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 3,974 shares of the software maker’s stock, valued at approximately $38,000.
Veradigm Company Profile
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Featured Articles
- Five stocks we like better than Veradigm
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Power Up: Gaming Industry Expansion Fuels Stock Opportunities
- Investing In Preferred Stock vs. Common Stock
- These 3 Quirky ETFs May Be Strong Plays in 2025
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Buffett Takes the Bait; Berkshire Buys More Oxy in December
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
